Lynn O'Connor Vos is the President and CEO of the Muscular Dystrophy Association (MDA), dedicated to transforming the lives of people affected by muscular dystrophy, ALS and related neuromuscular disease. She is focused on asserting MDA’s leadership in research and care and establishing MDA as the preeminent advocate and provider of services to families affected by neuromuscular disease. Lynn is leading MDA in the development of a comprehensive data hub, MOVR, which will drive the advancement of research, new technologies and care strategies and galvanize both the industry and research arenas to pioneer better care and more cures.
Prior to her arrival at MDA, Lynn was the CEO of ghg | greyhealth group for nearly 23 years. While at ghg, Vos led global expansion and diversification strategies and within two years grew the company from a small, domestic professional player into an award-winning global enterprise with fully integrated, multi-channel offerings.
Lynn has public and private board experience, including OptimizeRx (OTC: OPRX) and the board of The Jed Foundation, a leading mental health nonprofit. She was named Woman of the Year by the Healthcare Business Women’s Association in 2005, was nominated by the YWCA to the Academy of Women Achievers in 1999 and received the Corporate Achievement Award from The Jed Foundation in 2006. In addition to the numerous awards Lynn has won over the years, in 2017 she was named an MM&M Healthcare Transformer and a member of the PharmaVOICE 100; in 2016, a PM360 Elite Transformational Leader and an MM&M Top 50 Health Influencer. This year she was named a PharmaVOICE Red Jacket honoree.